Canadians are experiencing an overwhelming amount of marketing for the diabetes medications Ozempic and Rybelsus. Ads for these drugs can be found on different platforms, and even at professional sports games. Both Ozempic and Rybelsus, manufactured by Novo Nordisk, are semaglutide drugs approved for treating Type 2 diabetes. Doctors and experts fear that the extensive ads may pressure unnecessary prescriptions.
We'll keep you updated on all new application updates and features!